Back
ESC Professional Premium Access

Severity of chronic obstructive pulmonary disease and risk of one-year mortality after first-time implantation of implantable cardioverter defibrillator: a nationwide study

Session: Real-world data in ICD treatment
Topic: Implantable Cardioverter-Defibrillator (ICD)
Speaker: Doctor A. Alhakak (Copenhagen, DK)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Amna Alhakak

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
0 follower

5 more presentations in this session

Driving restrictions following defibrillator implantation significantly affect recipients' ability to maintain employment

Speaker: Doctor J. Bjerre (Hilleroed, DK)

Access
Abstract
Slides
Like
Thumbnail

History of betablocker treatment breaks and risk of ventricular tachyarrhythmias among patients with heart failure and implantable cardioverter defibrillator: a nationwide cohort study

Speaker: Miss E. Mc Evoy Kjaer (Copenhagen, DK)

Access
Abstract
Slides
Like
Thumbnail

Effect of defibrillator on long term all-cause mortality in patients with chronic kidney disease: an updated meta-analysis

Speaker: Doctor F. Aslam (Stony Brook, US)

Access
Abstract
Slides
Like
Thumbnail

The role of trigger factors in the occurrence of appropriate ICD shocks and their prognostic implications

Speaker: Doctor T. Kleemann (Ludwigshafen, DE)

Access
Abstract
Slides
Like
Thumbnail

The case against premature treatment of heart failure patients with implantable cardioverter-defibrillators: results from an institutional registry

Speaker: Doctor I. Prepolec (Zagreb, HR)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Real-world data in ICD treatment

Speakers: Doctor A. Alhakak, Doctor J. Bjerre, Miss E. Mc Evoy Kjaer, Doctor F. Aslam, Doctor T. Kleemann...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources